Evolution of recombinant factor VIII safety: KOGENATE^® and Kogenate^® FS/BayerLUSHER, Jeanne M; SCHARRER, Inge.International journal of hematology. 2009, Vol 90, Num 4, pp 446-454, issn 0925-5710, 9 p.Article

Phosphatidylserine Containing Liposomes Reduce Immunogenicity of Recombinant Human Factor VIII (rFVIII) in a Murine Model of Hemophilia ARAMANI, Karthik; MICLEA, Razvan D; PUROHIT, Vivek S et al.Journal of pharmaceutical sciences. 2008, Vol 97, Num 4, pp 1386-1398, issn 0022-3549, 13 p.Article

The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysisSHU HE; BLOMBÄCK, Margareta; BARK, Niklas et al.Thrombosis and haemostasis. 2010, Vol 103, Num 5, pp 1076-1084, issn 0340-6245, 9 p.Article

Passive Transfer of Polyethylene glycol to Liposomal-Recombinant Human FVIII Enhances its Efficacy in a Murine Model for Hemophilia ARAMANI, Karthik; PUROHIT, Vivek; MICLEA, Razvan et al.Journal of pharmaceutical sciences. 2008, Vol 97, Num 9, pp 3753-3764, issn 0022-3549, 12 p.Article